Pages that link to "Q33997122"

The following pages link to Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets (Q33997122):

Displaying 37 items.

• Alcoholic Liver Disease: Update on the Role of Dietary Fat (Q26769970) (← links)
• Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease (Q26825517) (← links)
• Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. (Q30372863) (← links)
• Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse (Q34185231) (← links)
• A minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkers (Q34326409) (← links)
• Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors (Q34704820) (← links)
• Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs. (Q35332874) (← links)
• Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model (Q35670899) (← links)
• Differential Ratios of Omega Fatty Acids (AA/EPA DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231 (Q35761006) (← links)
• Health implications of high dietary omega-6 polyunsaturated Fatty acids. (Q35909254) (← links)
• Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice (Q36096333) (← links)
• Omega-3 fatty acid deficiency augments risperidone-induced hepatic steatosis in rats: positive association with stearoyl-CoA desaturase (Q36164661) (← links)
• Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer (Q36273224) (← links)
• Omega-3 fatty acid supplementation and cardiovascular disease (Q36387184) (← links)
• Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity (Q36478196) (← links)
• Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice (Q36483906) (← links)
• Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease (Q37177378) (← links)
• Fatty acid-regulated transcription factors in the liver (Q37613511) (← links)
• Pharmacological agents for NASH. (Q38152646) (← links)
• Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways (Q38319585) (← links)
• Both maternal and offspring Elovl2 genotypes determine systemic DHA levels in perinatal mice. (Q38375706) (← links)
• Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice (Q38528762) (← links)
• α-Linolenic acid supplementation and exercise training reveal independent and additive responses on hepatic lipid accumulation in obese rats (Q38922349) (← links)
• PPARγ agonist-induced alterations in Δ6-desaturase and stearoyl-CoA desaturase 1: Role of MEK/ERK1/2 pathway. (Q39152313) (← links)
• Pre-natal undernutrition and post-natal overnutrition are associated with permanent changes in hepatic metabolism markers and fatty acid composition in sheep. (Q39299896) (← links)
• Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line. (Q39420124) (← links)
• n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial (Q40689561) (← links)
• Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids (Q43672282) (← links)
• Implication of trans-11,trans-13 conjugated linoleic acid in the development of hepatic steatosis. (Q49490030) (← links)
• Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol (Q58722819) (← links)
• Effects of a Diet Rich in n-3 Polyunsaturated Fatty Acids on Hepatic Lipogenesis and Beta-Oxidation in Mice (Q60513161) (← links)
• Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis (Q64055244) (← links)
• Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons (Q64108193) (← links)
• Dietary conjugated α-linolenic acid did not improve glucose tolerance in a neonatal pig model (Q85637158) (← links)
• The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH) (Q91781701) (← links)
• Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review (Q92626334) (← links)
• Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome (Q92753123) (← links)